Literature DB >> 17909565

Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasia.

G Godoy1, S S Taneja.   

Abstract

High-grade prostatic intraepithelial neoplasia (HGPIN) is a premalignant lesion associated with increased risk of coexistent cancer or delayed progression to carcinoma. Extended biopsy schemes have improved the ability to rule out concurrent cancers, increased the detection of isolated HGPIN and removed the routine necessity for immediate repeat biopsy. As the natural history of HGPIN is poorly defined, and no non-invasive marker allows monitoring of progression to cancer, routine delayed interval biopsy should be considered in all patients. In this article, we present an overview of the existing literature on HGPIN and a proposed strategy for clinical management.

Entities:  

Mesh:

Year:  2007        PMID: 17909565     DOI: 10.1038/sj.pcan.4501014

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  5 in total

Review 1.  What is the pathologist saying? Interpretation of the prostate pathology report.

Authors:  Omar Hameed
Journal:  Curr Urol Rep       Date:  2009-05       Impact factor: 3.092

2.  Inverted (hobnail) high-grade prostatic intraepithelial neoplasia and invasive inverted pattern.

Authors:  Meltem Öznur; Sevim Baykal Koca; Pelin Yildiz; Burak Bahadir; Kemal Behzatoğlu
Journal:  Oncol Lett       Date:  2015-08-10       Impact factor: 2.967

Review 3.  A Tale of Two Cancers: A Current Concise Overview of Breast and Prostate Cancer.

Authors:  Franklyn De Silva; Jane Alcorn
Journal:  Cancers (Basel)       Date:  2022-06-15       Impact factor: 6.575

Review 4.  Precursor lesions to prostatic adenocarcinoma.

Authors:  Jonathan I Epstein
Journal:  Virchows Arch       Date:  2008-12-02       Impact factor: 4.064

Review 5.  Inflammation in prostate cancer progression and therapeutic targeting.

Authors:  Timothy Stark; Lydia Livas; Natasha Kyprianou
Journal:  Transl Androl Urol       Date:  2015-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.